I am the Scientific Director of the Cardiothoracic
Research Program and Director of the Columbia Biobank for Translational
Science, an applied biobank supporting translational and precision
My main research interests are in heart valve and vascular cell physiology, cardiac mechanobiology, materials science in medical devices, and the brain-heart axis.
I am a Biomedical Researcher with a PhD in Physiology and
Endocrinology. My research focuses on the study of the advanced stages
of myocardial and cardiac valve remodeling. My research argues that
cardiac remodeling is regulated both at a local and systemic level and
that it may, in turn, affect remote tissues by endocrine
Currently, I am leading projects that explore myocardium-cardiac valve communication in the adaptation to ischemic injury and the role of circulating factors from the skeletal muscle in cardiac remodeling in end-stage heart failure.
(recommendations for mystery books welcome)
Dr. Camillo is a cellular biologist studying the molecular mechanisms that regulate endothelium and vascular morphogenesis. Broadly, her research focuses on translational and clinical approaches to studying cardiovascular diseases using both in vitro and in vivo models. Dr. Camillo is leading projects on thoracic aortic aneurysm development, focused on determining the impact of glycation products on cellular phenotype, extracellular matrix remodeling and aortic wall instability.
“Sciences provide an understanding of a universal experience, Arts
are a universal understanding of a personal experience… they are both a
part of us and a manifestation of the same thing… the arts and sciences
are avatars of human creativity” – Mae Jemison
Dr. Yingfei Xue is currently a postdoctoral research scientist in
Dr. Giovanni Ferrari lab at Columbia University. He obtained his PhD
degree from University
of Pittsburgh School of Pharmacy. His research interest is centered
around cardiovascular implants including bioprosthetic valves, conduits,
His research goal is to better understand the mechanisms of cardiovascular implant failure and improve implant durability. He has 20 publications and served as editorial board member and reviewer for multiple journals in the fields of biomedical engineering.
Erfan is a General Surgery resident undertaking a T32-funded postdoctoral fellowship at the Ferrari Lab, while pursuing a Master of Science in Biostatistics with the Columbia University Mailman School of Public Health. Prior to joining the lab, Erfan obtained his Bachelor of Science with Honors in Molecular, Cell, and Developmental Biology at UCLA. He then attended medical school at Oakland University William Beaumont School of Medicine in Michigan, where he developed his passion for a career in academic surgery. He has since pursued his surgical training at SUNY Downstate. Erfan’s research interests include investigating molecular drivers valve degeneration and cardiac tissue engineering, and cardiac surgical outcomes. In his spare time, Erfan enjoys kayaking, hiking, and exploring the New York food scene.
Sameer is a resident in the Integrated Cardiothoracic Surgery Program at Columbia University. He has completed three years of surgical residency and has clinical interests in heart failure, transplantation, and mechanical circulatory support. He obtained his MD from Northwestern University in Chicago, IL. Currently, with the support of the Thoracic Surgery Foundation (TSF) Resident Research Fellowship Award, he is studying the underlying mechanisms of structural valve degeneration specifically with regards to transcatheter valve technologies.
Dov is a General Surgery resident and aspiring Cardiac Surgeon currently pursuing a PhD in Cellular, Molecular, and Biomedical Studies with the Ferrari Lab. A local New Yorker, he attended medical school at Albert Einstein College of Medicine, and graduated with Alpha Omega Alpha and Distinction in Clinical Research honors. He then continued with his surgical training at Robert Wood Johnson University Hospital. His research interests include cellular mechanisms of thoracic aortic aneurysm development, including the role of Advanced Glycated End products (AGEs) on aortic wall instability.
Morehouse School of Medicine
Evan is a second-year medical student at Morehouse School of Medicine interested in a career in cardiothoracic surgery. Some of his research and clinical interests include patient outcomes research and minimally invasive surgical techniques.
2 years old Irish-Doodle. Strong interest in any type of food. Life’s not ruff when I am around. Woof
U of Bologna
Edoardo is a medical student in his fifth year at the Alma Mater Studiorum Università di Bologna. He developed an interest for cardiac surgery during his third year in medical school. His research and clinical interests involve the study of the aortic pathology, particularly the treatment of acute aortic syndrome and the sub-cellular mechanisms involved in its pathogenesis.
Mangesh was the lab manager for Ferrari Lab. He completed his Masters of Science in Pharmacology and Toxicology from Long Island University in Brooklyn, New York. His research background involved basic molecular and translational biology in cardiovascular, inflammation and infectious diseases. In his free time, he enjoys playing tennis, his guitar and taking long drives.
U of Milan
Nicolò Vitale is cardiac surgery resident at Università degli studi di Milano. He obtained his MD from Università degli studi di Milano. He is very interested in the mechanisms of ischemic heart failure. He studied the mechanisms of structural degeneration of the pediatric bioprosthetic conduits.
Alexey is a General Surgery resident in the New York Presbyterian-Columbia program with an interest in cardiothoracic surgery fellowship and biomedical engineering. He graduated from Emory University and received his MD from New York Medical College. He completed an NIH T32 post-doctoral research fellowship in Dr. Ferrari’s lab studying the underlying mechanisms of structural degeneration of bioprosthetic heart valves with next-generation proteomics. While in the lab, he also completed a Master’s degree in Biostatistics at the Columbia University Mailman School of Public Health. In his free time, he enjoys the outdoors, hiking, running, road cycling and skiing.
Vivian Moreno was the Clinical Research Coordinator for the Ferrari Lab. She completed her Bachelor’s of Science in Biomedical Science at the University of Kent in Canterbury, England. Her research background included cancer research at Yale University and novel antimicrobial peptides at NovaBiotics, Ltd. She is now pursuing advanced training in Hofstra Cardiovascular Medicine and Perfusion program.
Jessica was a Research Technician in the Ferrari Lab. A native New Yorker, she completed her Bachelor’s of Science in Biology and Women’s Gender and Sexuality Studies at Stony Brook University. While at Stony Brook, she conducted research pertaining to Chronic Myelogenous Leukemia (CML) in the lab of Dr. Markus Seeliger. Her interest in cardiovascular diseases and prevention led her to the Ferrari Lab where she provided support to the Biobank and various research projects. She is now a medical student at Albert Einstein College of Medicine.
Clinton is a resident in Integrated Cardiothoracic surgery at New York Presbyterian-Columbia. He obtained his MD from University of Alabama at Birmingham, where he developed an interest in cardiac surgery. While in lab, he studied mechanisms of cardiovascular damage related to COVID-19, along with several clinical projects in adult cardiac surgery.
Michael is a resident in the Integrated Cardiothoracic surgery at New York Presbyterian-Columbia. He obtained his MD from Columbia University College of Physicians & Surgeons. While in the lab, he studied pathologic mechanisms in mitral valve disease and was involved in several clinical projects across the spectrum of adult cardiac surgery.
Mar Martinez Mas was a Master’s student in Biomedical Engineering at Columbia
University. She is from Barcelona, Spain, and completed her
undergraduate degree at Universitat
Pompeu Fabra (Barcelona, Spain) where she worked in the field of
biomedical electronics. Afterward, she completed the last year and a
half of her degree at the Politecnico di
Milano (Milan, Italy), where she mainly studied the field of
Her main interest lies in prosthetic heart valves and life support systems. She joined the Ferrari Lab in 2021 and studied the mass and tissue thickening of cardiac valvular bioprostheses under different conditions. She has since joined the industry to advance her research development.
T-32 Postdoctoral Research Fellow (2016-2021)
General Surgery Resident (2018-2020)
Integrated Cardiothoracic (I-6) Surgery Resident (2019-2020)
General Surgery Resident (2019-2020)
Director of Cardiology Research
Program Director of the Cardiology National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant
Children’s Hospital of Philadelphia
Levy is the director of Cardiology Research, and also serves as program director of the Cardiology National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant.
His research interests are the pathophysiology of biomaterials used
in medicine, basic mechanisms and novel therapies for heart valve
disease, arterial angioplasty, local drug delivery, and nanomedicine. He
also has experience over three decades in medical device
Florence Irving Associate Professor of Surgery
Section of Pediatric & Congenital Cardiac Surgery
Director, Pediatric Heart Valve Center
Surgical Director, Initiative for Pediatric Cardiac Innovation
Columbia University College of Physicians and Surgeons
Expandable Polymeric-valved Conduit to Repair Congenital Heart Disease
The proposed research is relevant to public health because a
biostable polymeric valved conduit that can be implanted surgically to
reconstruct the right ventricular outflow tract in neonates and infants
and then expanded by successive transcatheter procedures to reach the
adult size, would revolutionize how we treat children with heart valve
diseases. Such a new generation of valved conduit would decrease the
number of open-heart surgeries and reoperations, decrease the mortality,
complications and healthcare costs related to these procedures and
increase the life expectancy and quality of life of these
University of Texas at Austin
The bicuspid aortic valve (BAV) is the most common cardiac congenital
anomaly. Due to the widespread availability and routine use of screening
echocardiography, development of clinical methods for the identification
of asymptomatic young patients with BAV is now realistic. We thus plan
to develop sensitive, clinically derivable functional indices that will
yield clinically relevant patient- specific strategies for identifying
BAV patients at high risk.
University of Ottawa Heart Institute
Canadian Institute of Research and Health (CIHR) Fellowship
Identification of Molecular Pathways that Protect Against
Atherosclerosis Coronary artery disease (CAD) is one of the leading
causes of cardiovascular death worldwide. Current treatments for CAD
include lifestyle modifications and medical therapies to reduce its risk
factors. When these methods fail, more invasive interventions, such as
placement of a stent to restore blood flow or performance of a coronary
artery bypass graft surgery, are used. This latter procedure aims at
bypassing the blocked area using either veins or arteries. The use of
arterial grafts is associated with a better long-term patency and a
reduced rate of progression of atherosclerosis when compared to vein
grafts. Yet, the exact molecular mechanisms by which arteries are
protected from disease progression are not well understood. This study
aims to identify the underlying mechanisms that render arteries
resistant to atherosclerosis.
Director, Cardiac Surgery
The Valley Hospital
Dr. Grau’s work blends clinical knowledge and expertise with the
tools of basic science to find new approaches to clinically relevant
problems. He serves as a reviewer for the Annals of Thoracic Surgery,
Journal of the American Heart Association, Circulation, and the British
Heart Foundation, among others.
Associate Professor of Radiology
Director of the Advanced Cardiovascular Imaging Lab at the University of Pennsylvania
University of Pennsylvania
Theoretical and applied advanced imaging, especially magnetic resonance imaging and quantitative cardiovascular imaging.
Created by Alexey Abramov MD
© Copyright 2022, Ferrari Lab at Columbia University